Compare NHC & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHC | QDEL |
|---|---|---|
| Founded | 1971 | 1979 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 1997 | 2022 |
| Metric | NHC | QDEL |
|---|---|---|
| Price | $156.17 | $23.78 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.75 |
| AVG Volume (30 Days) | 44.2K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | ★ 50.46 | 45.35 |
| EPS | ★ 6.10 | N/A |
| Revenue | $1,307,382,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.62 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | $26.45 | ★ N/A |
| Revenue Growth | ★ 14.53 | N/A |
| 52 Week Low | $89.14 | $19.50 |
| 52 Week High | $171.64 | $42.21 |
| Indicator | NHC | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 33.68 |
| Support Level | $158.28 | $22.70 |
| Resistance Level | $171.35 | $24.75 |
| Average True Range (ATR) | 5.59 | 1.73 |
| MACD | 0.21 | -0.54 |
| Stochastic Oscillator | 60.59 | 23.62 |
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.